stockrowThe Ensign Group, Inc.
ENSG Healthcare Medical Care Facilities
The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- +23.6%
- Free cash flow
- +89.2%
- Total debt
- +39.2%
Quarter to September 2026, against a year earlier
Follow ENSG
Alert me
The Ensign Group, Inc. (ENSG) Revenue
The Ensign Group, Inc.'s revenue for fiscal 2025 was $5.1B, up 18.7% from $4.3B in fiscal 2024. Over the twelve months to 30 September 2026 it was $5.7B. Over the past ten years it has ranged from $1.3B (fiscal 2015) to $5.1B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 8 consecutive fiscal years. The Ensign Group, Inc. ranks 13th of 47 Medical Care Facilities companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $5.1B | 18.72% |
| FY2024 | $4.3B | 14.24% |
| FY2023 | $3.7B | 23.27% |
| FY2022 | $3.0B | 15.15% |
| FY2021 | $2.6B | 9.36% |
| FY2020 | $2.4B | 17.98% |
| FY2019 | $2.0B | 16.07% |
| FY2018 | $1.8B | 9.78% |
| FY2017 | $1.6B | (3.42%) |
| FY2016 | $1.7B | 23.33% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $1.5B | 3.02% |
| Jun 2026 | $1.4B | 3.69% |
| Mar 2026 | $1.4B | 2.10% |
| Dec 2025 | $1.4B | 4.95% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | $22.6B |
| UHS Universal Health Services, Inc. compare | $18.4B |
| DVA DaVita Inc. compare | $14.2B |
| EHC Encompass Health Corporation compare | $6.3B |
| PACS PACS Group, Inc. compare | $5.7B |
| ENSG The Ensign Group, Inc. | $5.7B |
| CHE Chemed Corporation compare | $2.7B |
| CON Concentra Group Holdings Parent, Inc. compare | $2.3B |
| LFST LifeStance Health Group, Inc. compare | $1.7B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on ENSG
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement